The mevalonate pathway as a metabolic requirement for autophagy-implications for growth control, proteostasis, and disease

Teemu P. Miettinen; Mikael Björklund

doi:10.1080/23723556.2016.1143546

The mevalonate pathway as a metabolic requirement for autophagy-implications for growth control, proteostasis, and disease

Teemu P. Miettinen (Lead / Corresponding author)
, Mikael Björklund (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Abstract

Autophagy is responsible for the degradation and recycling of cellular proteins and organelles. Our recent work shows that the mevalonate pathway influences cell size, growth, and proteostasis by regulating basal autophagic flux through geranylgeranylation of the small GTPase RAB11. The control of autophagy by the mevalonate/cholesterol pathway has potential implications for statin toxicity, inflammation, cancer, and neurodegenerative diseases.

Original language	English
Article number	e1143546
Number of pages	3
Journal	Molecular and Cellular Oncology
Volume	3
Issue number	3
Early online date	18 Feb 2016
DOIs	https://doi.org/10.1080/23723556.2016.1143546
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1080/23723556.2016.1143546

Cite this

@article{e31e80d6df25461ab6326b06e4fc61da,

title = "The mevalonate pathway as a metabolic requirement for autophagy-implications for growth control, proteostasis, and disease",

abstract = "Autophagy is responsible for the degradation and recycling of cellular proteins and organelles. Our recent work shows that the mevalonate pathway influences cell size, growth, and proteostasis by regulating basal autophagic flux through geranylgeranylation of the small GTPase RAB11. The control of autophagy by the mevalonate/cholesterol pathway has potential implications for statin toxicity, inflammation, cancer, and neurodegenerative diseases.",

author = "Miettinen, \{Teemu P.\} and Mikael Bj{\"o}rklund",

year = "2016",

doi = "10.1080/23723556.2016.1143546",

language = "English",

volume = "3",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

publisher = "Taylor \& Francis",

number = "3",

}

TY - JOUR

T1 - The mevalonate pathway as a metabolic requirement for autophagy-implications for growth control, proteostasis, and disease

AU - Miettinen, Teemu P.

AU - Björklund, Mikael

PY - 2016

Y1 - 2016

N2 - Autophagy is responsible for the degradation and recycling of cellular proteins and organelles. Our recent work shows that the mevalonate pathway influences cell size, growth, and proteostasis by regulating basal autophagic flux through geranylgeranylation of the small GTPase RAB11. The control of autophagy by the mevalonate/cholesterol pathway has potential implications for statin toxicity, inflammation, cancer, and neurodegenerative diseases.

AB - Autophagy is responsible for the degradation and recycling of cellular proteins and organelles. Our recent work shows that the mevalonate pathway influences cell size, growth, and proteostasis by regulating basal autophagic flux through geranylgeranylation of the small GTPase RAB11. The control of autophagy by the mevalonate/cholesterol pathway has potential implications for statin toxicity, inflammation, cancer, and neurodegenerative diseases.

U2 - 10.1080/23723556.2016.1143546

DO - 10.1080/23723556.2016.1143546

M3 - Article

C2 - 27314093

SN - 2372-3556

VL - 3

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

IS - 3

M1 - e1143546

ER -

The mevalonate pathway as a metabolic requirement for autophagy-implications for growth control, proteostasis, and disease

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this